AMMAN – Talal Abu-Ghazaleh University
College for Innovation (TAGUCI), a member of Talal Abu-Ghazaleh Global
(TAG.Global), has concluded the ‘Advanced Business Management’ training
program, organized for cadres of the Axantia Company (Pharma International
Company in Jordan and Med City Pharmaceutical Industries in Saudi Arabia).

TAGUCI Dean, Dr. Naser Al-Nsor, stated
that the program was held as part of the University College’s mission in
spreading the culture of training and capacity-building in the fields of
management, entrepreneurship and administrative skills development. This is for
the urgent need of such skills in the labor market.

Dr. Al-Nsor expressed TAGUCI’s pride in
the interest of Axantia Company and participants in the program, attributed to
its importance in a time that the labor market has become in urgent need for
specialists in management, leadership and innovation.

For his part, Axantia Chief Executive
Officer, Dr. Abdulmonem Alali, praised the level of the program and topics
which effectively contribute to keeping participants abreast with necessary
professional, practical and scientific developments and changes, thanking the
University College for organizing the program.

It is worth mentioning that the Talal
Abu-Ghazaleh University College for Innovation (TAGUCI) is an independent
educational institution accredited by the Jordanian Ministry of Higher
Education and the Accreditation and Quality Assurance Commission for Higher
Education Institutions. It received membership in the Association to Advance
Collegiate Schools of Business (AACSB), and the Foundation for International
Business Administration Accreditation (FIBAA).

Axantia Company (Pharma International Company in
Jordan and Med City Pharmaceutical Industries in Saudi Arabia) is a regional
leading company in the field of pharmaceutical industry and manufacturing of
high-quality branded generic pharmaceuticals. It always strives to improve the
efficiency and quality of pharmaceuticals and deliver medicines and specialized
products at an affordable cost to patients and healthcare recipients.